Open-Label Phase 3 Long-Term Safety Study of Migalastat
Condition(s):Fabry DiseaseLast Updated:October 2, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Fabry DiseaseLast Updated:October 2, 2018Terminated
Condition(s):Fabry DiseaseLast Updated:October 16, 2018Completed
Condition(s):Fabry Disease; ProteinuriaLast Updated:March 18, 2014Completed
Condition(s):Fabry DiseaseLast Updated:June 29, 2016Completed
Condition(s):Left Ventricular HypertrophyLast Updated:February 3, 2021Unknown status
Condition(s):Fabry Disease; Chronic Kidney Disease, Stage IV (Severe)Last Updated:April 7, 2015Terminated
Condition(s):Fabry Disease; ProteinuriaLast Updated:November 19, 2013Completed
Condition(s):Fabry Disease; Fabry Disease, Cardiac VariantLast Updated:September 6, 2023Enrolling by invitation
Condition(s):Fabry DiseaseLast Updated:June 26, 2017Unknown status
Condition(s):Fabry DiseaseLast Updated:July 19, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.